Please enable JavaScript
Powered by Benchmark International Archives - Page 692 of 1814 - Matribhumi Samachar English
Thursday, January 08 2026 | 06:23:19 AM
Home / International (page 692)

International

Silver One Increases Private Financing to $6,016,600

Vancouver, British Columbia–(Newsfile Corp. – August 26, 2025) – Silver One Resources Inc. (TSXV: SVE) (OTCQX: SLVRF) (FSE: BRK1) (“Silver One” or the “Company”) is pleased to announce that due to an oversubscription, it has increased its previously announced non-brokered private placement financing to 21,487,857 units (a “Unit”) at a …

Read More »

Diamond Estates Wines & Spirits Reports Fiscal 2025 Financial Results

Niagara-on-the-Lake, Ontario–(Newsfile Corp. – August 26, 2025) – Diamond Estates Wines & Spirits Inc. (TSXV: DWS) (“Diamond Estates” or “the Company”) today announced its financial results of position for the three and twelve months ended March 31, 2025 (“Q4 2024” and “FY 2025” respectively). The completion of the Company’s audit …

Read More »

Excellon Announces Upsize of Brokered Private Placement of Common Shares for Gross Proceeds of up to C$11 Million

Toronto, Ontario–(Newsfile Corp. – August 26, 2025) – Excellon Resources Inc. (TSXV: EXN) (OTC Pink: EXNRF) (FSE: E4X2) (“Excellon” or the “Company“) is pleased to announce that as a result of strong investor demand, the Company has increased the size of its previously announced “best efforts” private placement (the “Offering“) …

Read More »

VIQ Solutions Announces Closing of Insider Led Private Placement

Mississauga, Ontario–(Newsfile Corp. – August 26, 2025) – VIQ Solutions Inc. (TSX: VQS) (“VIQ“, “VIQ Solutions” or the “Company“), a global provider of secure, AI-driven, digital voice and video capture technology and transcription services, is pleased to announce it has closed its previously announced non-brokered private placement of 2,640,290 units of the …

Read More »

Theralase(R) Releases 2Q2025 Financial Statements

Toronto, Ontario–(Newsfile Corp. – August 26, 2025) – Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) (“Theralase®” or the “Company“), a clinical stage pharmaceutical pioneering light, radiation, sound and drug-activated therapeutics for the treatment of cancer, bacteria and viruses has released the Company’s unaudited condensed consolidated interim 2Q2025 financial statements (“Financial Statements“). Theralase® …

Read More »

Sol Strategies Announces Fiscal Third Quarter 2025 Financial and Operating Results

Toronto, Ontario–(Newsfile Corp. – August 26, 2025) – SOL Strategies Inc. (CSE: HODL) (OTCQB: CYFRD) (formerly, Cypherpunk Holdings Inc, “Sol Strategies” or the “Company”), the first publicly traded company to combine a substantial Solana treasury with a revenue-generating validator business, today released its financial results for the fiscal third quarter …

Read More »